Puechal et al RTX vs CYC induction in GPA: target trial emulation study. BVAS 0 and pred=<10mg at 6 months 73% RTX vs 40% CYC. RR 1.82[95%CI:1.22;2.73] @RheumNow #ACR22 Abstr#1084 https://t.co/6e8wutMC2H https://t.co/OpeajFVdJf
Links:
Rituximab versus Cyclophosphamide for Induction Therapy in Granulomatosis with …
https://acrabstracts.org/abstract/rituximab-versus-cyclophosphamide-for-inducti…
13-11-2022


